{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:13:15Z","timestamp":1758042795083,"version":"3.44.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.reumae.2025.501913","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T12:54:53Z","timestamp":1755176093000},"page":"501913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paradoxical reaction after switching between adalimumab biosimilars in a patient with psoriatic arthritis"],"prefix":"10.1016","volume":"21","author":[{"given":"Mariano F.","family":"Palatnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilce S.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Lorena","family":"Brance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2025.501913_bib0045","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"Global psoriasis atlas. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.reumae.2025.501913_bib0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/1744666X.2014.866038","article-title":"Paradoxical effects of anti-TNF-\u03b1 agents in inflammatory diseases","volume":"10","author":"Wendling","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.reumae.2025.501913_bib0055","first-page":"49","article-title":"Adverse reactions to biologics","volume":"vol. 53","author":"Puig","year":"2018"},{"key":"10.1016\/j.reumae.2025.501913_bib0060","first-page":"1266","article-title":"The risk of paradoxical psoriasis in patients with inflammatory bowel disease treated with anti-TNF-\u03b1 agents: a systematic review and meta-analysis","volume":"15","author":"Gisondi","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.reumae.2025.501913_bib0065","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s13555-021-00511-1","article-title":"Comparative efficacy and relative ranking of biologics and oral therapies for moderate-to-severe plaque psoriasis: a network meta-analysis","volume":"11","author":"Armstrong","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.reumae.2025.501913_bib0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semarthrit.2010.04.003","article-title":"Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis","volume":"40","author":"Collamer","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.reumae.2025.501913_bib0075","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ad.2018.04.003","article-title":"Paradoxical reactions to biologic therapy in psoriasis: a review of the literature","volume":"109","author":"Munera-Campos","year":"2018","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"10.1016\/j.reumae.2025.501913_bib0080","doi-asserted-by":"crossref","first-page":"e000239","DOI":"10.1136\/rmdopen-2015-000239","article-title":"Paradoxical reactions under TNF-\u03b1 blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview","volume":"2","author":"Toussirot","year":"2016","journal-title":"RMD Open"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574325000917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574325000917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:15:24Z","timestamp":1757618124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574325000917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2173574325000917"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2025.501913","relation":{},"ISSN":["2173-5743"],"issn-type":[{"type":"print","value":"2173-5743"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paradoxical reaction after switching between adalimumab biosimilars in a patient with psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2025.501913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Reumatolog\u00eda (SER), Colegio Mexicano de Reumatolog\u00eda (CMR) and Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501913"}}